Lymphoma is a type of cancer that affects the lymphatic system, which plays a crucial role in immunity. With over 80 different types of lymphoma, it can be overwhelming for medical professionals to differentiate and understand each one. Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Mantle Cell Lymphoma – these are just some examples of the many variants of this disease. In this blog post, we will break down the different types of lymphoma and provide you with essential information on how fast it grows and its possible causes. As medical professionals, understanding these details is vital in diagnosing and treating patients efficiently. Let's dive deeper into what you need to know about lymphomas!
Lymphoma is a type of cancer that starts in the lymphatic system, which consists of lymph nodes, vessels, and organs. There are two primary types of lymphoma: Hodgkin Lymphoma (HL) and Non-Hodgkin Lymphoma (NHL).
Hodgkin Lymphoma is characterized by the presence of Reed-Sternberg cells in affected tissues. This type of lymphoma accounts for only 10% to 15% of all cases but has a higher cure rate than other types.
Non-Hodgkin Lymphomas represent around 85% to 90% of all cases. It originates from B cells or T cells and can have several subtypes depending on its molecular characteristics.
Mantle Cell Lymphoma is an aggressive subtype that arises from B-cells located at the mantle zone surrounding germinal centers in secondary follicles; it is challenging to treat due to its resistance to chemotherapy.
One of the most important factors to consider when dealing with lymphoma is how fast it grows. Lymphomas can grow at different rates, depending on various factors such as the type and stage of the disease.
Hodgkin lymphoma tends to grow more slowly than non-Hodgkin lymphomas. In fact, some patients may not experience any symptoms for several years after being diagnosed with Hodgkin's.
On the other hand, aggressive non-Hodgkin lymphomas can grow very rapidly and require immediate treatment. These types of lymphomas often cause significant symptoms such as fever, night sweats and weight loss.
The exact cause of lymphoma is still unknown, but researchers have identified several risk factors that may increase the likelihood of developing this type of cancer. One potential cause is a weakened immune system due to certain infections, such as HIV or Epstein-Barr virus. Exposure to radiation and certain chemicals can also increase the risk.
Additionally, genetic mutations may play a role in the development of lymphoma. Some people with a family history of lymphoma are at higher risk for developing the disease themselves.
Age also plays an important factor in developing lymphoma. Most cases occur in individuals over 60 years old, although it can affect people of any age.
Hodgkin Lymphoma is one of the most treatable forms of cancer with high survival rates, while Non-Hodgkin Lymphomas are more diverse in nature and can be challenging to diagnose due to their similarities with other diseases. It's essential to conduct an accurate diagnosis through biopsy or imaging tests to determine the appropriate treatment method.
1.
Finding a clue to the origin of treatment-resistant leukemia in kids
2.
Survivors of childhood brain cancer are more likely to be held back in school
3.
TCL1A Protein Identified as Predictor of Blinatumomab Response in Relapsed B-ALL
4.
Adding Daratumumab to VRd Boosts MRD Negativity in Transplant-Ineligible Myeloma
5.
Utilizing cerium/lanthanum-134 to improve cancer detection and treatment.
1.
Phosphate Vs. Phosphorus: What Is The Difference?
2.
Strategic Deals and FDA Approvals Transforming U.S. Oncology Drug Development
3.
Exploring the Mysteries of MGUS: Uncovering the Causes and Treatments
4.
What Is May-Hegglin Anomaly? Understanding this Rare Blood Disorder
5.
Exploring the Benefits of Flexible Sigmoidoscopy: A Revolutionary Way to Detect Colorectal Cancer
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part I
2.
Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
3.
Influence of CDK4/6 Inhibitors in Extending Progression-Free Survival (PFS) and Overall Survival in HR+/HER2- mBC Patients
4.
Efficient Management of First line ALK-rearranged NSCLC - Part III
5.
Evolution in Treatment and Diagnosis of Lung Cancer- An Initiative from Manipal Hospitals
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation